HealthStream Posts Record Q2 Revenue and Lifts Full-Year Outlook
HSTM sits 45% above its 52-week low of $19.5.
Summary
HealthStream posted record Q2 2026 revenue of $83.7M (+12.5% YoY) and raised full-year guidance, demonstrating strong business momentum despite a recent cybersecurity incident.
Key Events · Earnings and Guidance · HSTM
-
Record Q2 Revenue
Revenue reached $83.7 million, a 12.5% increase from $74.4 million in Q2 2025, driven by subscription growth and acquisitions.
-
Profitability Surge
Operating income rose 41.4% to $8.3 million; net income grew 23.8% to $6.7 million, or $0.23 per diluted share.
-
Raised Full-Year Guidance
Revenue guidance lifted to $327–332 million (from $323–330 million); Adjusted EBITDA now seen at $74–78 million (from $73–77 million).
-
Dividend Declared
Board declared a quarterly cash dividend of $0.035 per share, payable August 28 to shareholders of record August 17.
Analysis · HSTM · Technology
Coming just days after a disclosed cybersecurity breach, HealthStream's record quarterly revenue of $83.7 million—up 12.5% year-over-year—and a 41.4% surge in operating income provide a powerful counterbalance for investors gauging the company's resilience. The raised full-year revenue and Adjusted EBITDA guidance further signal management's confidence in sustained demand for its clinical workforce solutions.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 28.8% of the 1640 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.58%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HSTM was trading at $28.33 on NASDAQ in the Technology sector, with a market capitalization of approximately $827.7M. The 52-week trading range was $19.50 to $30.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.